| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 11/20/2002 | EP1017684B1 Contrasting agent for infarct and necrosis imaging |
| 11/19/2002 | CA2155931C Inhibitors of thrombosis |
| 11/14/2002 | WO2002090351A1 Process for producing carbostyril derivative |
| 11/14/2002 | US20020169215 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology |
| 11/13/2002 | EP1256341A1 Cancer remedy comprising anthranilic acid derivative as active ingredient |
| 11/13/2002 | CN1379766A Benzoic acid derivatives for treatment of diabetes mellitus |
| 11/12/2002 | US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity |
| 11/12/2002 | US6479518 Zwitterionic tachykinin receptor antagonists |
| 11/12/2002 | US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/12/2002 | US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example |
| 11/12/2002 | CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists |
| 11/07/2002 | WO2002048119A3 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
| 11/07/2002 | US20020165365 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 11/07/2002 | US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 11/07/2002 | US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 11/07/2002 | US20020165200 Central nervous system disorders |
| 11/06/2002 | EP1254901A1 Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient |
| 11/06/2002 | EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| 11/06/2002 | EP1030843A4 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 11/06/2002 | CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 11/06/2002 | CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 11/06/2002 | CN1377881A Intermediate for preparing cascade polymeric ligand and contrast medium |
| 11/05/2002 | US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity |
| 11/05/2002 | US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 11/05/2002 | CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same |
| 10/31/2002 | WO2002085413A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 10/31/2002 | US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis |
| 10/31/2002 | US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
| 10/31/2002 | US20020161030 Sulpur derivatives containing a retroamide bond as inhibitors of endothelin-converting enzymes |
| 10/24/2002 | WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 10/24/2002 | WO2002083127A1 Protein modification-inhibitory compositions |
| 10/24/2002 | WO2002067999A3 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 10/24/2002 | US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors |
| 10/23/2002 | CN1376145A A meta-nitro phenol derivative and a process for producing it |
| 10/22/2002 | US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis |
| 10/22/2002 | US6468502 Paramagnetic macromolecules with higher proton relaxivity; lower dosage and increased signal intensity; detecting vascular diseases; differentiating tissue blood supply levels; distinguishing myocardial infarction from ischemia |
| 10/22/2002 | CA2227264C Amine acid salt compounds and process for the production thereof |
| 10/17/2002 | WO2002081435A1 Sulphones which modulate the action of gamma secretase |
| 10/16/2002 | EP0998466B1 A process for the preparation of tetraazamacrocycles |
| 10/16/2002 | EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 10/15/2002 | US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 10/10/2002 | WO2002058636A3 Novel cannabimimetic ligands |
| 10/10/2002 | US20020147336 Glucocorticoid receptor modulators |
| 10/09/2002 | EP0918840B1 Metal ligand containing bleaching compositions |
| 10/09/2002 | EP0853477B1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 10/09/2002 | CN1373660A Method for treating chronic pain using MEK inhibitors |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 10/03/2002 | WO2002076395A2 Agents and methods for treatment of cancer |
| 10/03/2002 | US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
| 10/03/2002 | CA2441394A1 Agents and methods for treatment of cancer |
| 10/02/2002 | EP1244648A1 Chemokine receptor binding heterocyclic compounds |
| 10/02/2002 | CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection |
| 10/01/2002 | US6458998 Naphthaleneureas as antidiabetic agents |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | CA2261589C Long-lived homogenous oxidation catalysts |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/25/2002 | EP1242399A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 09/24/2002 | US6455550 N-alkanoylphenylalanine derivatives |
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/19/2002 | WO2002072506A2 7-pyrollyl tetracycline compounds and methods of use thereof |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020133007 Potato and corn crops |
| 09/18/2002 | EP1117633B1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 09/18/2002 | EP0994881B1 Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes |
| 09/18/2002 | EP0989974B1 A process for the preparation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid and the derivatives thereof |
| 09/18/2002 | EP0828709B1 Novel physically functional materials |
| 09/18/2002 | CN1370153A Herbicidal tetrazolinone derivatives |
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | CA2057338C Diarylfluoromethane compounds |
| 09/12/2002 | WO2002070494A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | US20020128472 N-(6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl)-1,4,7,10 -tetraazacyclododecane or its complex reacted with lithium chlroide or lithium bromide with chloro or bromoacetic acid and lithium hydroxide |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/11/2002 | EP0973729B1 A process for the preparation of 4-bromomethyl diphenyl compounds |
| 09/11/2002 | EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 09/11/2002 | CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives |
| 09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein |
| 09/10/2002 | CA2129339C Inhibitors of thrombosis |
| 09/06/2002 | WO2002067999A2 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 09/04/2002 | EP0914320B1 A process for the preparation of tetraazamacrocycles |
| 09/03/2002 | US6444840 Bone disorders; vision defects |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | WO2002024235A3 Prochelators of radiometal labeled molecules |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| 08/29/2002 | US20020119910 Drug delivery |
| 08/29/2002 | CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/27/2002 | US6441180 Tetrazolyl-phenyl actamide glucokinase activators |
| 08/27/2002 | US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity |
| 08/27/2002 | US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |